Clinical Trial Update: Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis [NA]

View source ↗

Summary

Clinical trial update describing a study of Yishen Daluo Yin Granule for relapsing-remitting multiple sclerosis; the trial status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Yishen Daluo Yin Granule

Snippet

Sponsor: Ying Gao | Conditions: Relapse Remitting Multiple Sclerosis | NA | Status: NOT_YET_RECRUITING